{"id":"W2328501245","doi":"10.1097/igc.0b013e31826d1438","title":"Expected Benefits of Topotecan Combined With Lapatinib in Recurrent Ovarian Cancer According to Biological Profile","year":2012,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":false,"ca_institutions":"Centre d'expertise et de recherche en infrastructures urbaines","funders":"","keywords":"Topotecan; Medicine; Lapatinib; Internal medicine; Oncology; Gefitinib; Epidermal growth factor receptor; Cancer; Chemotherapy; Pharmacology; Trastuzumab; Breast cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006371661,0.0001658433,0.0005373696,0.0003315776,0.00002550108,0.00001805545,0.0003950925,0.0001408284,0.003429211],"category_scores_gemma":[0.0009468388,0.0001062326,0.0001073522,0.0004105372,0.00009679684,0.0001327968,0.0001319174,0.0005520354,0.000007146403],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009866119,"about_ca_system_score_gemma":0.0004425851,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002581011,"about_ca_topic_score_gemma":0.0002931523,"domain_scores_codex":[0.997668,0.0001209992,0.0006951264,0.0001994267,0.0009028365,0.0004135774],"domain_scores_gemma":[0.9978028,0.0003190098,0.0003624102,0.0001190866,0.001064773,0.0003319243],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.005804246,0.0008623593,0.9096294,0.00002890112,0.0002085078,0.00008030917,0.0004830833,0.0002902469,0.004012851,0.0004827534,0.0007978747,0.07731944],"study_design_scores_gemma":[0.003484227,0.003652209,0.9799126,0.0007598841,0.00003169602,0.00007195902,0.0003841128,0.00004684161,0.008323247,0.00005481206,0.003108078,0.0001702712],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9912357,0.001050137,0.00006202969,0.005108033,0.001113905,0.0004509138,0.00005672698,0.00001242139,0.0009101006],"genre_scores_gemma":[0.9962279,0.0004898885,0.00170965,0.0005967229,0.0007301824,0.0001592043,0.00000674967,0.00001561706,0.00006406879],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.07714918,"threshold_uncertainty_score":0.9974818,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.09748817472018313,"score_gpt":0.4124924580605192,"score_spread":0.315004283340336,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}